Pfizer, BioNTech share positive early data on mRNA vaccine candidate BNT162b2 against Covid-19

Pfizer and BioNTech have shared positive early data on mRNA vaccine candidate BNT162b2 against Covid-19. (Credit: PIRO4D from Pixabay)